The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83(5):537-47.
Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 1995;45-328-51.
Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91(5):535-40.
Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg Oral Med Oral Pathol 1984;57(4):379-82.
Prevention, early detection and diagnosis of oral cancer. Dermatol Clin. 1987 Oct;5(4):675-80.
Autofluorescence imaging and spectroscopy of normal and malignant mucosa in patients with head and neck cancer. Lasers Surg Med 1999;25:323-34.
Diagnosis of oral cancer by light-induced autofluorescence spectroscopy using double excitation wavelengths. Oral Oncol 1999;35:144-50.
Fluoresecence spectroscopy: a technique with potential to improve the early detection of aerodigestive tract neoplasia. Head Neck 1998;20:556-62.
Characterization of autofluroescence in oral squamous cell carcinoma. Oral Oncol 2003;39:150-6.
A comparative study of normal inspection, autofluourescence and 5-ALA-induced PPIX fluorescence for oral cnacer diagnosis. Int J Cancer 2002;97:245-52.
Detection and diagnosis of oral cancer by light-induced fluorescence. Lasers Surg Med 2003;32(1):17-24.
Fluorescence imaging and spectroscopy of 5-aminolevulinic acid induced protoporphyrin IX for the detection of neoplastic lesions in the oral cavity. Am J Surg 1996;172(6):674-7.
Analysis of fluorescence in oral squamous cell carcinoma. Oral Oncol 2002;38(4):343-8.
Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma. Cancer 2003;97(7):1681-92.
Roodenburg JL. Autofluorescence characteristics of healthy oral mucosa at different anatomical sites. Lasers Surg Med 2003;32(5):367-76.
Computer-assisted analysis of oral brush biopsies at an oral cancer screening program. J Am Dent Assoc 2002 Mar;133(3):357-62.
Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. J Am Dent Assoc 1999;130(10):1445-57.
Oral brush biopsy: the problem of false positives. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:252.
The oral brush biopsy: separating fact from fiction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:654-5.
Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent. 2002;50:500-3.
Naked-eye inspection of the cervix after acetic acid application may improve the predictive value of negative cytologic screening. J Fam Prac 1994;39:457-460.
Comparison of chemiluminescent light versus incandescent light in the visualization of acetowhite epithelium. Am J Gynecol Health 1992;6:11-15.
Papanicolaou smear screening augmented by a magnified chemiluminescent exam. Int J Gynecol Obstet 1993;43:289-296.
Comparison of magnified chemiluminescent examination with incandescent light examination and colposcopy for detection of cervical neoplasia. Ind J of Ca 1998;35:81-87.
Effectiveness of the Papanicolaou smear and speculoscopy as compared with the Papanicolaou smear alone: A community-based clinical trial. Obstet Gynecol 1997;90(3):421-427.
Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence Int 2004;35(5):378-84.
Correlation of imaging and clinical features in the assessment of mandibular invasion of oral carcinomas. Int J Oral Maxillofac Surg 1996;25(6):439-45.
CT and MR imaging in tumors of the tongue, tongue base, and floor of the mouth: a comparative study. J Belge Radiol 1994 Apr;77(2):78-83.
CT and MR imaging of squamous cell carcinoma of the tongue and floor of the mouth. Radiographics 1996;16(4):787-810.
Diagnostic value of magnetic resonance imaging for malignant tumors in the oral and maxillofacial region. Diagnostic value of magnetic resonance imaging for malignant tumors in the oral and maxillofacial region. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82(6):691-7.
Computed tomography of carcinoma of the upper gingiva and hard palate: correlation with the surgical and histopathological findings. Dentomaxillofac Radiol 1997;26(3):177-82.
Assessment of tumour invasion into the mandible: the value of different imaging techniques. Eur Radiol 1998;8(9):1552-7.
Predictors of carcinomatous invasion of the mandible. Head Neck 1994;16(2):116-26.
Mandibular invasion by squamous cell carcinoma: a computed tomographic and histological study. Br J Oral Maxillofac Surg 1996;34(1):69-74.
A comparison of segmental and marginal bony resection for oral squamous cell carcinoma involving the mandible. J Oral Maxillofac Surg 1997;55(5):470-7; discussion 477-8.
Head and neck sites. In AJCC Cancer Staging Manual, ed 6. New York: Springer-Verlag, 2002:17-88.
Recent advances in radiotherapy for head and neck cancers. Ear Nose Throat J 2001;80:704-17.
Postoperative irradiation with or without concommintant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-52.
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44.
Management of cancer of the head and neck – a cocktail with your PORT? N Engl J Med 2004;350:1997-9.
Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 2000;47(1):1-12.
Concurrent chemoradiotherapy in head and neck cancer. Curr Oncol Rep 1999;1(2)105-9. Review.
Morbidity after midline mandibulotomy and radiation therapy. Am J Otolaryngol 2000;21:312-7.
Cancer of retromolar trigone: Long-term radiation therapy outcome. Head Neck 2001;23:758-63.
Clinical function after primary surgery for oral and oropharyngeal cancer: An 11-item examination. Br J Oral Maxillofac Surgeons 2002;40:1-10.
Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. Br J Cancer 2002;86:517-23.
Late morbidity: The Damocles sword of radiotherapy? Radiother Oncol 2001;61:219-221.
Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. Radiother Oncol 2000;57:119-24.
Altered fractionation: limited by mucosal reactions? Radiother Oncol 1998;50:247-60.
R. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol 1996;40:137-45.
Conformal radiotherapy and intensity-modulated radiotherapy. Acta Oncologica 2000;39:555-67.
Dysphagia following chemoradiation for locally advanced head and neck cancer. Annals Oncol 2004;15:383-8.
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy – results of a m ulticentric randomized German trial in advanced head-and-necek cancer. Int J Rad Oncol Biol Phys 2001;50:1161-71.
Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy? Oral Oncol 2004;40(2):110-9. Review.
Accumulative increase in loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity. Cancer 2001;92:2349-56.
Deciphering gene expression profiled generated from DNA microarrays and their applications in oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:584-91.
The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 2000;29:413-25.
The prognostic significance of alleleic imbalance at key chromosomal loci in oral cancer. Br J Cancer 1999;79:1821-7.
A case-controlled study confirms that microsatellite assay can identify patients at risk of developing oral squamaous cell carcinoma within a field of cancerization. Cancer Res 2000;60:3893-8.
Impact of genomic instability in risk assessment and chemoprevention of oral premalignancies. Int J Cancer 2002;101:205-9.
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000;6:357-62.
The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004;350:1405-13.
Which putatively pre-malignant oral lesions become oral cancers? J Oral Pathol Med 2003;32:63-70.
Loss of heterozygosity: a potential tool in management of oral premalignant lesions? J Oral Pathol Med 2001;30:513-20.
Two sides of a prevention ‘coin’: adequate screening and better tools. J Oral Pathol Med 2002;31:249-51.
The head and neck radiation oncology patient. Quintessence Int 2003;34(9):693-717.
The medical oncology patient. Quintessence Int. 2005 May;36(5):383-402.